4. Original Alere LAM review, main findings.
Type of analysis | Symptomatic participants | Unselected participants | ||||
Studies (total participants) | Pooled sensitivity (95% CrI) | Pooled specificity (95% CrI) | Studies (total participants) | Pooled sensitivity (95% CrI) | Pooled specificity (95% CrI) | |
Overall accuracy | 5 studies (2313) | 45% (29% to 63%) | 92% (80% to 97%) | 3 studiesa (1055 ) | 30% (20% to 43%) | 94% (86% to 97%) |
By setting | ||||||
Inpatient | 4 studies (1299) | 53% (38% to 70%) | 90 % (73% to 96%) | Insufficient data | ||
Outpatient | Insufficient data | Insufficient data |
Abbreviations: LF‐LAM: lateral flow urine lipoarabinomannan assay (Alere Determine™ TB lipoarabinomannan assay); Crl: credible interval
Main findings from the original review on LF‐LAM accuracy (Shah 2016). aReported at grade 1 on the previous reference scale card with five bands that is outdated and no longer the recommended positivity threshold.